EducationSingle Daily HIV Pill Shows Promising Phase 3 Trial Results From UK Research
A Queen Mary University-led trial found a new combined bictegravir-lenacapavir tablet could replace complex multi-drug regimens for HIV…
EducationA Queen Mary University-led trial found a new combined bictegravir-lenacapavir tablet could replace complex multi-drug regimens for HIV…
HealthNHS data shows progress on the 28-day faster diagnosis standard but the 62-day treatment target remains significantly off…